Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

NCT02239224 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: ATYR1940

Sponsor

aTyr Pharma, Inc.